Alligator Bioscience AB (publ)
SSE:ATORX.ST
1.178 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7.577 | 6.977 | 11.738 | 19.414 | 17.362 | 9.593 | 20.061 | 5.108 | 5.17 | 5.356 | 5.249 | 3.3 | 3.777 | 0.617 | 0.166 | 0.28 | 4.352 | 0 | -0.001 | 4.288 | 0.03 | 0.04 | 25.626 | 0.197 | 0.392 | 0.776 | 51.299 | 1.77 | 1.283 | 2.523 | 6.433 | 4.661 | 3.787 | 43.36 | 0.511 | 289.286 |
| Cost of Revenue
| 34.343 | 43.026 | 58.398 | 52.471 | 56.456 | 72.276 | 47.378 | 36.34 | 30.756 | 30.146 | 24.811 | 24.539 | 19.992 | 17.64 | 19.686 | 17.383 | 20.157 | 25.094 | 41.303 | 46.115 | 30.025 | 27.932 | 39.312 | 27.564 | 23.516 | 30.77 | 22.459 | 17.143 | 19.716 | 12.753 | 15.118 | 7.861 | 21.42 | 12.36 | 17.859 | 9.596 |
| Gross Profit
| -26.766 | -36.049 | -46.66 | -33.057 | -39.094 | -62.683 | -27.317 | -31.232 | -25.586 | -24.79 | -19.562 | -21.239 | -16.215 | -17.023 | -19.52 | -17.103 | -15.805 | -25.094 | -41.304 | -41.827 | -29.995 | -27.892 | -13.686 | -27.367 | -23.124 | -29.994 | 28.84 | -15.373 | -18.433 | -10.23 | -8.685 | -3.2 | -17.633 | 31 | -17.348 | 279.69 |
| Gross Profit Ratio
| -3.533 | -5.167 | -3.975 | -1.703 | -2.252 | -6.534 | -1.362 | -6.114 | -4.949 | -4.628 | -3.727 | -6.436 | -4.293 | -27.59 | -117.59 | -61.082 | -3.632 | 0 | 41,304 | -9.754 | -999.833 | -697.3 | -0.534 | -138.919 | -58.99 | -38.652 | 0.562 | -8.685 | -14.367 | -4.055 | -1.35 | -0.687 | -4.656 | 0.715 | -33.949 | 0.967 |
| Reseach & Development Expenses
| 43.54 | 54.817 | 71.108 | 62.952 | 70.433 | 60.092 | 65.634 | 47.064 | 39.297 | 38.056 | 38.067 | 21.771 | 27.81 | 22.475 | 25.089 | 23.288 | 29.347 | 32.528 | 47.713 | 52.025 | 38.983 | 34.88 | 44.075 | 30.945 | 28.957 | 35.516 | 33.03 | 18.282 | 21.956 | 14.714 | 19.781 | 8.355 | 19.862 | 10.755 | 18.61 | 9.695 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 56.456 | 0 | 0 | 39.446 | 30.756 | 30.146 | -43.227 | 24.539 | 19.992 | 17.64 | -49.416 | 17.383 | 20.157 | 25.094 | -90.713 | 46.115 | 30.025 | 27.932 | -65.259 | 28.019 | 24.034 | 31.447 | -31.002 | 17.143 | 19.716 | 12.753 | -19.401 | 7.861 | 21.42 | 12.36 | 21.731 | 9.596 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.449 | 9.78 | 9.512 | 6.987 | 56.456 | 18.339 | 4.443 | 39.446 | 30.756 | 30.146 | -43.227 | 24.539 | 19.992 | 17.64 | -49.416 | 17.383 | 20.157 | 25.094 | -90.713 | 46.115 | 30.025 | 27.932 | -65.259 | 28.019 | 24.034 | 31.447 | -31.002 | 17.143 | 19.716 | 12.753 | -19.401 | 7.861 | 21.42 | 12.36 | 21.731 | 9.596 |
| Other Expenses
| 0 | 0 | 0 | 0 | 24.593 | 72.384 | 72.034 | 17.082 | 20.303 | 18.425 | 84.785 | 16.483 | 18.277 | 15.069 | 82.458 | 13.489 | 19.433 | -0.765 | 148.063 | -0.735 | -0.446 | -0.905 | 118.903 | 12.615 | 15.466 | 13.322 | 72.016 | 9.251 | 11.039 | 8.986 | 48.589 | 5.932 | 8.213 | 6.875 | 19.889 | 5.364 |
| Operating Expenses
| 52.989 | 64.597 | 80.62 | 72.361 | 81.049 | 72.384 | 72.034 | 56.528 | 51.059 | 48.571 | 41.558 | 41.022 | 38.269 | 32.709 | 33.042 | 30.872 | 39.59 | 44.882 | 57.35 | 62.889 | 50.627 | 46.663 | 53.644 | 40.634 | 39.5 | 44.769 | 41.014 | 26.394 | 30.755 | 21.739 | 29.188 | 13.793 | 29.633 | 19.235 | 41.62 | 14.96 |
| Operating Income
| -47.698 | -60.146 | -71.554 | -52.72 | -63.686 | -62.191 | -52.459 | -51.419 | -45.888 | -43.023 | -36.873 | -37.679 | -34.492 | -32.521 | -34.103 | -30.633 | -34.709 | -44.853 | -59.307 | -58.467 | -50.507 | -46.238 | -30.06 | -39.918 | -39.108 | -43.994 | 10.733 | -24.459 | -29.452 | -19.121 | -22.13 | -9.131 | -47.678 | 24.091 | -39.112 | 274.327 |
| Operating Income Ratio
| -6.295 | -8.621 | -6.096 | -2.716 | -3.668 | -6.483 | -2.615 | -10.066 | -8.876 | -8.033 | -7.025 | -11.418 | -9.132 | -52.708 | -205.44 | -109.404 | -7.975 | 0 | 59,307 | -13.635 | -1,683.567 | -1,155.95 | -1.173 | -202.629 | -99.765 | -56.693 | 0.209 | -13.819 | -22.956 | -7.579 | -3.44 | -1.959 | -12.59 | 0.556 | -76.54 | 0.948 |
| Total Other Income Expenses Net
| -1.514 | -2.606 | 1.724 | 0.219 | -0.026 | -0.352 | -0.792 | 0.054 | 0.177 | -0.053 | 0.023 | 0.477 | -0.467 | -0.032 | -1.474 | 0.024 | 0.186 | 2.002 | -2.414 | 1.968 | 1.281 | 2.224 | -2.571 | 0.802 | 1.497 | 1.784 | 2.231 | -1.148 | -1.528 | -0.286 | 3.407 | 1.587 | -19.216 | -0.526 | 1.659 | 4.244 |
| Income Before Tax
| -49.212 | -62.752 | -69.83 | -52.501 | -63.712 | -62.543 | -53.251 | -51.365 | -45.711 | -43.076 | -36.79 | -37.245 | -34.959 | -32.741 | -34.516 | -30.848 | -35.052 | -42.88 | -59.764 | -56.633 | -49.316 | -44.399 | -30.589 | -39.635 | -37.611 | -42.209 | 12.516 | -25.772 | -31 | -19.502 | -19.348 | -7.545 | -45.062 | 23.599 | -39.45 | 278.57 |
| Income Before Tax Ratio
| -6.495 | -8.994 | -5.949 | -2.704 | -3.67 | -6.52 | -2.654 | -10.056 | -8.842 | -8.043 | -7.009 | -11.286 | -9.256 | -53.065 | -207.928 | -110.171 | -8.054 | 0 | 59,764 | -13.207 | -1,643.867 | -1,109.975 | -1.194 | -201.193 | -95.946 | -54.393 | 0.244 | -14.56 | -24.162 | -7.73 | -3.008 | -1.619 | -11.899 | 0.544 | -77.202 | 0.963 |
| Income Tax Expense
| 0 | 2.483 | 2.628 | 0.37 | 0.026 | 0.352 | 0.823 | -0.054 | -0.177 | 0.053 | -0.023 | 0 | 0 | 0.188 | -1.947 | 0.256 | 0.528 | 2.213 | -2.349 | 2.084 | -0.011 | -0.012 | -7.456 | 2.11 | 2.166 | 4.692 | -3.685 | 0.778 | 0.722 | 1.473 | 2.517 | 1.941 | 3.925 | 0.225 | 1.659 | 4.244 |
| Net Income
| -49.212 | -62.752 | -69.83 | -52.501 | -63.738 | -62.895 | -54.074 | -51.311 | -45.534 | -43.129 | -36.79 | -37.245 | -34.959 | -32.741 | -34.516 | -30.848 | -35.052 | -42.88 | -59.764 | -56.633 | -49.306 | -44.386 | -30.589 | -39.635 | -37.611 | -42.209 | 12.516 | -25.772 | -31 | -19.502 | -19.348 | -7.545 | -45.062 | 23.599 | -39.45 | 278.57 |
| Net Income Ratio
| -6.495 | -8.994 | -5.949 | -2.704 | -3.671 | -6.556 | -2.695 | -10.045 | -8.807 | -8.052 | -7.009 | -11.286 | -9.256 | -53.065 | -207.928 | -110.171 | -8.054 | 0 | 59,764 | -13.207 | -1,643.533 | -1,109.65 | -1.194 | -201.193 | -95.946 | -54.393 | 0.244 | -14.56 | -24.162 | -7.73 | -3.008 | -1.619 | -11.899 | 0.544 | -77.202 | 0.963 |
| EPS
| -0.066 | -0.095 | -0.11 | -0.083 | -0.19 | -0.29 | -0.15 | -0.23 | -0.21 | -0.12 | -0.22 | -0.26 | -0.26 | -0.26 | -0.4 | -0.24 | -0.27 | -0.33 | -0.45 | -0.42 | -0.37 | -0.33 | -0.23 | -0.3 | -0.28 | -0.31 | 0.096 | -0.19 | -0.23 | -0.15 | -0.16 | -0.069 | -0.41 | 0.22 | -0.36 | 2.12 |
| EPS Diluted
| -0.066 | -0.095 | -0.11 | -0.083 | -0.19 | -0.29 | -0.15 | -0.23 | -0.21 | -0.12 | -0.22 | -0.26 | -0.26 | -0.26 | -0.4 | -0.24 | -0.27 | -0.33 | -0.45 | -0.42 | -0.37 | -0.33 | -0.23 | -0.3 | -0.28 | -0.31 | 0.096 | -0.19 | -0.23 | -0.15 | -0.16 | -0.057 | -0.34 | 0.18 | -0.3 | 2.12 |
| EBITDA
| -45.412 | -57.62 | -68.882 | -49.666 | -60.86 | -59.72 | -46.036 | -50.135 | -44.546 | -40.221 | -34.218 | -34.781 | -31.215 | -30.191 | -32.12 | -27.728 | -31.81 | -39.804 | -56.832 | -53.627 | -46.307 | -41.378 | -33.97 | -36.804 | -35.476 | -37.892 | 7.652 | -23.096 | -28.036 | -17.055 | -19.585 | -6.532 | 0.838 | 24.954 | -28.582 | 279.177 |
| EBITDA Ratio
| -5.993 | -8.259 | -5.868 | -2.558 | -3.505 | -6.225 | -2.295 | -9.815 | -8.616 | -7.51 | -6.519 | -10.54 | -8.264 | -48.932 | -193.494 | -99.029 | -7.309 | 0 | 56,832 | -12.506 | -1,543.567 | -1,034.45 | -1.326 | -186.822 | -90.5 | -48.83 | 0.149 | -13.049 | -21.852 | -6.76 | -3.044 | -1.401 | 0.221 | 0.576 | -55.933 | 0.965 |